Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Epstein-Barr virus BRLF1 inhibits transcription of IRF3 and IRF7 and suppresses induction of interferon-beta.

Bentz GL, Liu R, Hahn AM, Shackelford J, Pagano JS.

Virology. 2010 Jun 20;402(1):121-8. doi: 10.1016/j.virol.2010.03.014. Epub 2010 Apr 8.

2.

MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1.

Jung YJ, Choi H, Kim H, Lee SK.

J Virol. 2014 Aug;88(16):9027-37. doi: 10.1128/JVI.00721-14. Epub 2014 Jun 4.

3.

The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1.

Hong GK, Delecluse HJ, Gruffat H, Morrison TE, Feng WH, Sergeant A, Kenney SC.

J Virol. 2004 May;78(10):4983-92.

4.
5.

Interferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1.

Hahn AM, Huye LE, Ning S, Webster-Cyriaque J, Pagano JS.

J Virol. 2005 Aug;79(15):10040-52.

6.
7.
8.

Epstein-Barr virus LF2: an antagonist to type I interferon.

Wu L, Fossum E, Joo CH, Inn KS, Shin YC, Johannsen E, Hutt-Fletcher LM, Hass J, Jung JU.

J Virol. 2009 Jan;83(2):1140-6. doi: 10.1128/JVI.00602-08. Epub 2008 Nov 5.

10.

A Rhesus Rhadinovirus Viral Interferon (IFN) Regulatory Factor Is Virion Associated and Inhibits the Early IFN Antiviral Response.

Morin G, Robinson BA, Rogers KS, Wong SW.

J Virol. 2015 Aug;89(15):7707-21. doi: 10.1128/JVI.01175-15. Epub 2015 May 13.

12.
13.
14.

Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins.

Li L, Su X, Choi GC, Cao Y, Ambinder RF, Tao Q.

BMC Cancer. 2012 Mar 29;12:125. doi: 10.1186/1471-2407-12-125.

15.
16.

Inhibition of transcription of the beta interferon gene by the human herpesvirus 6 immediate-early 1 protein.

Jaworska J, Gravel A, Fink K, Grandvaux N, Flamand L.

J Virol. 2007 Jun;81(11):5737-48. Epub 2007 Mar 21.

17.

Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.

Feng WH, Westphal E, Mauser A, Raab-Traub N, Gulley ML, Busson P, Kenney SC.

J Virol. 2002 Nov;76(21):10951-9.

18.

Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo.

Westphal EM, Mauser A, Swenson J, Davis MG, Talarico CL, Kenney SC.

Cancer Res. 1999 Apr 1;59(7):1485-91.

19.

Contribution of myocyte enhancer factor 2 family transcription factors to BZLF1 expression in Epstein-Barr virus reactivation from latency.

Murata T, Narita Y, Sugimoto A, Kawashima D, Kanda T, Tsurumi T.

J Virol. 2013 Sep;87(18):10148-62. doi: 10.1128/JVI.01002-13. Epub 2013 Jul 10.

20.

Essential role of mitochondrial antiviral signaling, IFN regulatory factor (IRF)3, and IRF7 in Chlamydophila pneumoniae-mediated IFN-beta response and control of bacterial replication in human endothelial cells.

Buss C, Opitz B, Hocke AC, Lippmann J, van Laak V, Hippenstiel S, Kr├╝ll M, Suttorp N, Eitel J.

J Immunol. 2010 Mar 15;184(6):3072-8. doi: 10.4049/jimmunol.0902947. Epub 2010 Feb 12.

Supplemental Content

Support Center